chr10-103447178-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015916.5(CALHM2):āc.946G>Cā(p.Val316Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000745 in 1,611,296 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_015916.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CALHM2 | NM_015916.5 | c.946G>C | p.Val316Leu | missense_variant | 4/4 | ENST00000260743.10 | NP_057000.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CALHM2 | ENST00000260743.10 | c.946G>C | p.Val316Leu | missense_variant | 4/4 | 1 | NM_015916.5 | ENSP00000260743.5 | ||
CALHM2 | ENST00000369788.7 | c.946G>C | p.Val316Leu | missense_variant | 4/4 | 2 | ENSP00000358803.3 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152246Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000241 AC: 6AN: 249334Hom.: 0 AF XY: 0.0000297 AC XY: 4AN XY: 134790
GnomAD4 exome AF: 0.00000754 AC: 11AN: 1459050Hom.: 0 Cov.: 32 AF XY: 0.00000551 AC XY: 4AN XY: 725430
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152246Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74378
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 16, 2023 | The c.946G>C (p.V316L) alteration is located in exon 4 (coding exon 2) of the CALHM2 gene. This alteration results from a G to C substitution at nucleotide position 946, causing the valine (V) at amino acid position 316 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at